<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Velcade-Doxil-Dexamethasone Regimen Followed By Post-Transplant Revlimid May Be A Highly Effective Treatment For Newly Diagnosed Myeloma Patients</title>
	<atom:link href="http://www.myelomabeacon.com/news/2010/02/02/velcade-doxil-dexamethasone-regimen-followed-by-post-transplant-revlimid-may-be-a-highly-effective-treatment-for-newly-diagnosed-myeloma-patients/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.myelomabeacon.com/news/2010/02/02/velcade-doxil-dexamethasone-regimen-followed-by-post-transplant-revlimid-may-be-a-highly-effective-treatment-for-newly-diagnosed-myeloma-patients/</link>
	<description>The Myeloma Beacon provides extensive news, articles, and directories related to multiple myeloma. Its mission is to be the leading Internet resource for multiple myeloma patients, their families, and others interested in multiple myeloma.</description>
	<lastBuildDate>Fri, 30 Jul 2010 22:08:42 -0400</lastBuildDate>
	
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	</channel>
</rss>
